Search details
1.
Association of patient, treatment and disease characteristics with patient-reported outcomes: Results of the ECHO Registry.
Haemophilia
; 30(1): 106-115, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38030962
2.
Barriers and facilitators in diagnosing axial spondyloarthritis: a qualitative study.
Rheumatol Int
; 44(5): 863-884, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38472441
3.
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
Haemophilia
; 29(3): 743-752, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36811304
4.
Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review.
Dig Dis Sci
; 67(12): 5444-5454, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35288834
5.
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
Haemophilia
; 27(6): 932-937, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34403546
6.
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.
N Engl J Med
; 377(9): 819-828, 2017 08 31.
Article
in English
| MEDLINE | ID: mdl-28691885
7.
The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
J Pharmacol Exp Ther
; 374(1): 16-23, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32245884
8.
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.
Haemophilia
; 26(6): 966-974, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-33094894
9.
Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.
Haemophilia
; 25(2): 205-212, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30408835
10.
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Haemophilia
; 25(3): 398-407, 2019 May.
Article
in English
| MEDLINE | ID: mdl-31066174
11.
Emicizumab in Hemophilia A.
N Engl J Med
; 382(8): 785, 2020 02 20.
Article
in English
| MEDLINE | ID: mdl-32074440
12.
Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Blood
; 126(3): 397-405, 2015 Jul 16.
Article
in English
| MEDLINE | ID: mdl-25911238
13.
Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.
Blood
; 124(23): 3389-97, 2014 Nov 27.
Article
in English
| MEDLINE | ID: mdl-25339360
14.
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.
Blood
; 122(11): 1954-62, 2013 Sep 12.
Article
in English
| MEDLINE | ID: mdl-23926300
15.
Acquired haemophilia: an easy diagnosis to miss in a patient taking warfarin.
Acute Med
; 14(3): 122-4, 2015.
Article
in English
| MEDLINE | ID: mdl-26767201
16.
The principal results of the International Immune Tolerance Study: a randomized dose comparison.
Blood
; 119(6): 1335-44, 2012 Feb 09.
Article
in English
| MEDLINE | ID: mdl-22101900
17.
Expecting the unexpected: Acquired haemophilia A in a patient with homozygous factor V deficiency.
Haemophilia
; 25(2): e101-e103, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30690823
18.
Management of pregnancy in type 3 von Willebrand disease with alloantibodies.
Br J Haematol
; 182(3): 440-442, 2018 08.
Article
in English
| MEDLINE | ID: mdl-28699647
19.
Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom.
Blood
; 117(23): 6367-70, 2011 Jun 09.
Article
in English
| MEDLINE | ID: mdl-21471523
20.
Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B.
J Thromb Haemost
; 21(4): 850-861, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36696222